Key Market Indicators
The Luxembourg blood and blood forming organs medicine market is set to reach $27 million by 2026, up from $23 million in 2021. This marks an average year-on-year growth rate of 2.4%. The Luxembourger market has seen a surge of 7.7% year-on-year since 2000. In 2021, Luxembourg was ranked 29th in the world, overtaken by Costa Rica with a market of $23 million. Germany, Italy and South Korea came in at numbers 2, 3 and 4 respectively. Similarly, the Luxembourger anemia prevalence is expected to reach 456 hospital discharges by 2026, up from 427 in 2021, with a Compound Annual Growth Rate (CAGR) of 1%. Since 2003, there has been a year-on-year growth of 1.1%. In 2021, Luxembourg was ranked 31st worldwide, slightly behind Costa Rica's 427 hospital discharges. Germany, the United Kingdom and Poland claimed the top three spots in the ranking.
